Skip to main content

Our Next Pathology Oncology Digital Series:

February 26, 2026

Our Next Pathology
Oncology Digital Series:

February 26, 2026

REGISTER FOR THE NEXT CAMP PODS CLICK HERE

WELCOME

CAMP PODS is a webinar series, consisting of nine one-hour sessions that will take place from January to November 2026 for an hour once a month.

The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed.  Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.

Overall Learning Objectives:

By the end of the webinar series, an audience member will:

  1. Establish a strong Oncology Education Network
  2. Compare ideas, thoughts and common challenges
  3. Identify gaps and find team solutions for improving patient care
  4. Integrate pathology and oncology practices

NEXT CAMP PODS SESSION

Thursday, February 26, 2026
9:00am – 9:45 am PT Emerging Immunohistochemical Biomarkers in Ovarian Cancer Basile Tessier-Cloutier, MD

Consultant Gynecologic Pathologist, McGill University Health Centre (MUHC)
Principal Investigator, Research Institute (RI-MUHC)
Montreal, QC
9:45am  – 10:00am PT Questions & Answers
Learning objectives:
By the end of this presentation, participants will be able to:

  1. Present and discuss emerging immunohistochemical biomarkers in ovarian cancer and their impact on clinical decision-making.
  2. Review current and potential practices of immunohistochemistry testing in ovarian cancer.
  3. Discuss how pathology findings integrate with molecular and immunohistochemical results to guide personalized treatment strategies

OUR LAST CAMP PODS SESSION

Wednesday, January 28, 2026
9:00am – 9:45 am PT Current Diagnosis of Mesenchymal Neoplasms: A Fusion Between Anatomic and Molecular Pathology Jinesa Moodley, MB BCh BAO, FRCPC

Consultant Pathologist, BC Cancer Vancouver
Vancouver, BC
9:45am  – 10:00am PT Questions & Answers
Learning objectives:
By the end of this presentation, participants will be able to:

  1. Explain currently available and most utilized molecular testing for mesenchymal neoplasms
  2. Illustrate the relevance of molecular data in classification of mesenchymal neoplasms
  3. Justify the “why” and “when” of sending out for additional molecular testing for mesenchymal tumor classification
Close Menu